Director Marty M Reaume filed a Form 144 notice of proposed sale of 4,536 shares of SPS Commerce, Inc. common stock on November 3, 2026, following the exercise of options under a registered plan.
Jazz Pharmaceuticals Public Limited Company officer and director Renee D. Gala filed a Form 144 notice on November 3, 2026, disclosing a proposed sale of 1,000 shares of common stock on NASDAQ.
Tradeweb Markets Inc. officer Enrico Bruni filed a Form 144 notice on November 3, 2026, disclosing a proposed sale of 18,500 shares of common stock acquired through the exercise of options under a registered plan.
Incyte Corporation officer Thomas Tray filed a Form 144 notice of proposed sale of 610 shares of Incyte common stock on November 3, 2026, through Morgan Stanley Smith Barney LLC Executive Financial Services.
William D. Jenkins Jr., an officer of Palo Alto Networks, Inc., filed a Form 144 notice of proposed sale of securities on November 3, 2026, disclosing plans to sell 18,955 shares of common stock on NASDAQ.
Nurix Therapeutics Inc officer Christine Ring filed a Form 144 notice on November 3, 2026, disclosing a proposed sale of 6,113 shares of common stock with an aggregate market value of $157,104.10, to be executed on NASDAQ through Morgan Stanley Smith Barney LLC.
HSKB Funds II, LLC, a 10% owner of ZoomInfo Technologies Inc., filed a Statement of Changes in Beneficial Ownership on November 3, 2026, reporting a distribution of 19,001 shares of ZoomInfo common stock on November 1, 2026.
F5, Inc. officer Angelique Okeke filed a Form 144 notice on November 3, 2026, disclosing a proposed sale of 1,007 shares of F5 common stock through Morgan Stanley Smith Barney LLC Executive Financial Services.
F5 Inc officer John Maddison filed a Form 144 notice on November 3, 2026, proposing the sale of 619 shares of F5 Inc common stock on NASDAQ with an aggregate market value of $200,896.45.
F5, Inc. officer Chad Whalen filed a Form 144 notice of proposed sale of 6,950 shares of F5 common stock, dated November 3, 2026, pursuant to Rule 144 under the Securities Act of 1933.